AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $1.885B
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
| CIP | CIP Q3 FY18 Operating Update | PRICE SENSITIVE | 23/04/18 | |
| CIP | Distribution Reinvestment Plan - Issue Price | 20/04/18 | ||
| CIP | Update - Dividend/Distribution - CIP | 20/04/18 | ||
| CIP | Goldman Sachs Small & Mid-Cap Conference Presentation | PRICE SENSITIVE | 18/04/18 | |
| CIP | Dividend/Distribution - CIP | 23/03/18 | ||
| CIP | CIP March 2018 Distribution Declaration - Update | PRICE SENSITIVE | 23/03/18 | |
| CIP | CIP March 2018 Distribution Declaration | PRICE SENSITIVE | 23/03/18 | |
| CIP CIP Q3 FY18 Operating Update | |||
| 23/04/18 | PRICE SENSITIVE | ||
| CIP Distribution Reinvestment Plan - Issue Price | |||
| 20/04/18 | |||
| CIP Update - Dividend/Distribution - CIP | |||
| 20/04/18 | |||
| CIP Goldman Sachs Small & Mid-Cap Conference Presentation | |||
| 18/04/18 | PRICE SENSITIVE | ||
| CIP Dividend/Distribution - CIP | |||
| 23/03/18 | |||
| CIP CIP March 2018 Distribution Declaration - Update | |||
| 23/03/18 | PRICE SENSITIVE | ||
| CIP CIP March 2018 Distribution Declaration | |||
| 23/03/18 | PRICE SENSITIVE | ||
